TGTX
TG Therapeutics, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $898M | +426.7% |
| Gross profit | $743M | — |
| Operating income | $193M | — |
| Net income | $106M | — |
| EPS | $0.66 | — |
| Free cash flow | $86M | — |
TG Therapeutics, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $898M | +426.7% |
| Gross profit | $743M | — |
| Operating income | $193M | — |
| Net income | $106M | — |
| EPS | $0.66 | — |
| Free cash flow | $86M | — |